Project
averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for POU5F1_POU2F3
Z-value: 3.90
Motif logo
Transcription factors associated with POU5F1_POU2F3
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
POU5F1
|
ENSG00000204531.11 | POU class 5 homeobox 1 |
|
POU2F3
|
ENSG00000137709.5 | POU class 2 homeobox 3 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| POU2F3 | hg19_v2_chr11_+_120107344_120107351 | 0.30 | 5.3e-06 | Click! |
| POU5F1 | hg19_v2_chr6_-_31138439_31138475 | 0.20 | 3.0e-03 | Click! |
Activity profile of POU5F1_POU2F3 motif
Sorted Z-values of POU5F1_POU2F3 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr2_+_90060377 | 91.79 |
ENST00000436451.2
|
IGKV6D-21
|
immunoglobulin kappa variable 6D-21 (non-functional) |
| chr2_+_90248739 | 83.44 |
ENST00000468879.1
|
IGKV1D-43
|
immunoglobulin kappa variable 1D-43 |
| chr2_+_90139056 | 83.06 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
| chr2_-_89399845 | 82.87 |
ENST00000479981.1
|
IGKV1-16
|
immunoglobulin kappa variable 1-16 |
| chr2_+_90108504 | 78.23 |
ENST00000390271.2
|
IGKV6D-41
|
immunoglobulin kappa variable 6D-41 (non-functional) |
| chr2_+_90077680 | 75.77 |
ENST00000390270.2
|
IGKV3D-20
|
immunoglobulin kappa variable 3D-20 |
| chr14_-_107049312 | 72.79 |
ENST00000390627.2
|
IGHV3-53
|
immunoglobulin heavy variable 3-53 |
| chr2_+_89998789 | 69.92 |
ENST00000453166.2
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
| chr2_-_89340242 | 66.20 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
| chr2_+_90121477 | 64.87 |
ENST00000483379.1
|
IGKV1D-17
|
immunoglobulin kappa variable 1D-17 |
| chr22_+_22786288 | 63.97 |
ENST00000390301.2
|
IGLV1-36
|
immunoglobulin lambda variable 1-36 |
| chr2_-_89521942 | 62.30 |
ENST00000482769.1
|
IGKV2-28
|
immunoglobulin kappa variable 2-28 |
| chr22_+_23077065 | 61.74 |
ENST00000390310.2
|
IGLV2-18
|
immunoglobulin lambda variable 2-18 |
| chr2_+_89975669 | 61.04 |
ENST00000474213.1
|
IGKV2D-30
|
immunoglobulin kappa variable 2D-30 |
| chr2_-_89442621 | 59.35 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
| chr14_-_107078851 | 58.55 |
ENST00000390628.2
|
IGHV1-58
|
immunoglobulin heavy variable 1-58 |
| chr21_+_10862622 | 58.42 |
ENST00000302092.5
ENST00000559480.1 |
IGHV1OR21-1
|
immunoglobulin heavy variable 1/OR21-1 (non-functional) |
| chr16_+_33605231 | 56.84 |
ENST00000570121.2
|
IGHV3OR16-12
|
immunoglobulin heavy variable 3/OR16-12 (non-functional) |
| chr2_+_90198535 | 56.54 |
ENST00000390276.2
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
| chr2_-_89597542 | 55.48 |
ENST00000465170.1
|
IGKV1-37
|
immunoglobulin kappa variable 1-37 (non-functional) |
| chr14_-_106539557 | 55.36 |
ENST00000390599.2
|
IGHV1-8
|
immunoglobulin heavy variable 1-8 |
| chr2_-_89266286 | 54.90 |
ENST00000464162.1
|
IGKV1-6
|
immunoglobulin kappa variable 1-6 |
| chr2_+_89923550 | 54.78 |
ENST00000509129.1
|
IGKV1D-37
|
immunoglobulin kappa variable 1D-37 (non-functional) |
| chr14_-_107083690 | 54.15 |
ENST00000455737.1
ENST00000390629.2 |
IGHV4-59
|
immunoglobulin heavy variable 4-59 |
| chr14_-_107095662 | 52.77 |
ENST00000390630.2
|
IGHV4-61
|
immunoglobulin heavy variable 4-61 |
| chr2_-_89545079 | 52.62 |
ENST00000468494.1
|
IGKV2-30
|
immunoglobulin kappa variable 2-30 |
| chr22_+_23134974 | 52.13 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
| chr22_+_22707260 | 51.50 |
ENST00000390293.1
|
IGLV5-48
|
immunoglobulin lambda variable 5-48 (non-functional) |
| chr2_-_89459813 | 50.92 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
| chr16_+_32077386 | 50.48 |
ENST00000354689.6
|
IGHV3OR16-9
|
immunoglobulin heavy variable 3/OR16-9 (non-functional) |
| chr14_-_107170409 | 49.99 |
ENST00000390633.2
|
IGHV1-69
|
immunoglobulin heavy variable 1-69 |
| chr22_+_22712087 | 49.92 |
ENST00000390294.2
|
IGLV1-47
|
immunoglobulin lambda variable 1-47 |
| chr14_-_106552755 | 49.83 |
ENST00000390600.2
|
IGHV3-9
|
immunoglobulin heavy variable 3-9 |
| chr2_+_90192768 | 49.80 |
ENST00000390275.2
|
IGKV1D-13
|
immunoglobulin kappa variable 1D-13 |
| chr2_-_89417335 | 48.69 |
ENST00000490686.1
|
IGKV1-17
|
immunoglobulin kappa variable 1-17 |
| chr16_+_33020496 | 47.78 |
ENST00000565407.2
|
IGHV3OR16-8
|
immunoglobulin heavy variable 3/OR16-8 (non-functional) |
| chr14_-_106573756 | 47.13 |
ENST00000390601.2
|
IGHV3-11
|
immunoglobulin heavy variable 3-11 (gene/pseudogene) |
| chr14_-_107114267 | 47.09 |
ENST00000454421.2
|
IGHV3-64
|
immunoglobulin heavy variable 3-64 |
| chr2_+_90153696 | 46.89 |
ENST00000417279.2
|
IGKV3D-15
|
immunoglobulin kappa variable 3D-15 (gene/pseudogene) |
| chr2_+_89890533 | 45.74 |
ENST00000429992.2
|
IGKV2D-40
|
immunoglobulin kappa variable 2D-40 |
| chr22_+_23063100 | 45.11 |
ENST00000390309.2
|
IGLV3-19
|
immunoglobulin lambda variable 3-19 |
| chr22_+_22735135 | 44.81 |
ENST00000390297.2
|
IGLV1-44
|
immunoglobulin lambda variable 1-44 |
| chr15_-_22473353 | 44.00 |
ENST00000557788.2
|
IGHV4OR15-8
|
immunoglobulin heavy variable 4/OR15-8 (non-functional) |
| chr22_+_23154239 | 43.64 |
ENST00000390315.2
|
IGLV3-10
|
immunoglobulin lambda variable 3-10 |
| chr22_+_23089870 | 43.36 |
ENST00000390311.2
|
IGLV3-16
|
immunoglobulin lambda variable 3-16 |
| chr14_-_106733624 | 43.34 |
ENST00000390610.2
|
IGHV1-24
|
immunoglobulin heavy variable 1-24 |
| chr4_-_71532339 | 42.31 |
ENST00000254801.4
|
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
| chr2_+_89952792 | 42.01 |
ENST00000390265.2
|
IGKV1D-33
|
immunoglobulin kappa variable 1D-33 |
| chr2_-_89619904 | 41.51 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 (gene/pseudogene) |
| chr14_-_106830057 | 40.28 |
ENST00000390616.2
|
IGHV4-34
|
immunoglobulin heavy variable 4-34 |
| chr16_-_33647696 | 40.25 |
ENST00000558425.1
ENST00000569103.2 |
RP11-812E19.9
|
Uncharacterized protein |
| chr5_-_172198190 | 39.05 |
ENST00000239223.3
|
DUSP1
|
dual specificity phosphatase 1 |
| chr16_+_32063311 | 38.34 |
ENST00000426099.1
|
AC142381.1
|
AC142381.1 |
| chr22_+_23165153 | 38.04 |
ENST00000390317.2
|
IGLV2-8
|
immunoglobulin lambda variable 2-8 |
| chr2_+_68962014 | 37.99 |
ENST00000467265.1
|
ARHGAP25
|
Rho GTPase activating protein 25 |
| chr16_+_23847267 | 37.64 |
ENST00000321728.7
|
PRKCB
|
protein kinase C, beta |
| chr14_-_106926724 | 37.44 |
ENST00000434710.1
|
IGHV3-43
|
immunoglobulin heavy variable 3-43 |
| chr22_+_23101182 | 37.41 |
ENST00000390312.2
|
IGLV2-14
|
immunoglobulin lambda variable 2-14 |
| chr2_+_87565634 | 37.36 |
ENST00000421835.2
|
IGKV3OR2-268
|
immunoglobulin kappa variable 3/OR2-268 (non-functional) |
| chr22_+_23040274 | 37.24 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
| chr10_-_98031265 | 37.19 |
ENST00000224337.5
ENST00000371176.2 |
BLNK
|
B-cell linker |
| chr2_-_90538397 | 37.10 |
ENST00000443397.3
|
RP11-685N3.1
|
Uncharacterized protein |
| chr2_+_89901292 | 36.74 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
| chr10_-_98031310 | 36.59 |
ENST00000427367.2
ENST00000413476.2 |
BLNK
|
B-cell linker |
| chr14_-_106963409 | 35.74 |
ENST00000390621.2
|
IGHV1-45
|
immunoglobulin heavy variable 1-45 |
| chr2_+_90273679 | 35.55 |
ENST00000423080.2
|
IGKV3D-7
|
immunoglobulin kappa variable 3D-7 |
| chr14_-_106845789 | 35.55 |
ENST00000390617.2
|
IGHV3-35
|
immunoglobulin heavy variable 3-35 (non-functional) |
| chr18_-_52989217 | 34.84 |
ENST00000570287.2
|
TCF4
|
transcription factor 4 |
| chr14_-_106878083 | 34.79 |
ENST00000390619.2
|
IGHV4-39
|
immunoglobulin heavy variable 4-39 |
| chr2_-_89278535 | 34.52 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
| chr2_+_89184868 | 33.76 |
ENST00000390243.2
|
IGKV4-1
|
immunoglobulin kappa variable 4-1 |
| chr2_-_89327228 | 33.68 |
ENST00000483158.1
|
IGKV3-11
|
immunoglobulin kappa variable 3-11 |
| chr16_+_23847339 | 33.54 |
ENST00000303531.7
|
PRKCB
|
protein kinase C, beta |
| chr2_+_114163945 | 33.46 |
ENST00000453673.3
|
IGKV1OR2-108
|
immunoglobulin kappa variable 1/OR2-108 (non-functional) |
| chr19_-_1021113 | 33.44 |
ENST00000333175.5
ENST00000356663.3 |
TMEM259
|
transmembrane protein 259 |
| chr14_-_106478603 | 33.30 |
ENST00000390596.2
|
IGHV4-4
|
immunoglobulin heavy variable 4-4 |
| chr2_-_89568263 | 32.56 |
ENST00000473726.1
|
IGKV1-33
|
immunoglobulin kappa variable 1-33 |
| chr2_+_89986318 | 31.69 |
ENST00000491977.1
|
IGKV2D-29
|
immunoglobulin kappa variable 2D-29 |
| chr2_+_90458201 | 31.66 |
ENST00000603238.1
|
CH17-132F21.1
|
Uncharacterized protein |
| chrX_-_106960285 | 31.36 |
ENST00000503515.1
ENST00000372397.2 |
TSC22D3
|
TSC22 domain family, member 3 |
| chr2_-_89385283 | 31.14 |
ENST00000390252.2
|
IGKV3-15
|
immunoglobulin kappa variable 3-15 |
| chr2_+_90211643 | 31.02 |
ENST00000390277.2
|
IGKV3D-11
|
immunoglobulin kappa variable 3D-11 |
| chr16_+_33006369 | 30.78 |
ENST00000425181.3
|
IGHV3OR16-10
|
immunoglobulin heavy variable 3/OR16-10 (non-functional) |
| chr6_-_32557610 | 30.62 |
ENST00000360004.5
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1 |
| chr6_+_32407619 | 30.02 |
ENST00000395388.2
ENST00000374982.5 |
HLA-DRA
|
major histocompatibility complex, class II, DR alpha |
| chr7_-_100183742 | 29.78 |
ENST00000310300.6
|
LRCH4
|
leucine-rich repeats and calponin homology (CH) domain containing 4 |
| chr12_-_91574142 | 29.69 |
ENST00000547937.1
|
DCN
|
decorin |
| chr22_+_22764088 | 28.75 |
ENST00000390299.2
|
IGLV1-40
|
immunoglobulin lambda variable 1-40 |
| chr1_-_153363452 | 28.46 |
ENST00000368732.1
ENST00000368733.3 |
S100A8
|
S100 calcium binding protein A8 |
| chr3_+_186648307 | 28.13 |
ENST00000457772.2
ENST00000455441.1 ENST00000427315.1 |
ST6GAL1
|
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
| chr22_+_22930626 | 27.81 |
ENST00000390302.2
|
IGLV2-33
|
immunoglobulin lambda variable 2-33 (non-functional) |
| chr6_-_32784687 | 27.79 |
ENST00000447394.1
ENST00000438763.2 |
HLA-DOB
|
major histocompatibility complex, class II, DO beta |
| chr3_+_186648274 | 27.27 |
ENST00000169298.3
|
ST6GAL1
|
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
| chr22_+_23046750 | 27.23 |
ENST00000390307.2
|
IGLV3-22
|
immunoglobulin lambda variable 3-22 (gene/pseudogene) |
| chr2_-_89513402 | 26.93 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
| chr14_-_106994333 | 26.76 |
ENST00000390624.2
|
IGHV3-48
|
immunoglobulin heavy variable 3-48 |
| chr2_-_89247338 | 26.37 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
| chr1_-_149858227 | 26.31 |
ENST00000369155.2
|
HIST2H2BE
|
histone cluster 2, H2be |
| chr14_-_106610852 | 25.90 |
ENST00000390603.2
|
IGHV3-15
|
immunoglobulin heavy variable 3-15 |
| chr7_+_26438187 | 25.62 |
ENST00000439120.1
ENST00000430548.1 ENST00000421862.1 ENST00000449537.1 ENST00000420774.1 ENST00000418758.2 |
AC004540.5
|
AC004540.5 |
| chr18_-_52989525 | 25.47 |
ENST00000457482.3
|
TCF4
|
transcription factor 4 |
| chr14_-_106692191 | 25.39 |
ENST00000390607.2
|
IGHV3-21
|
immunoglobulin heavy variable 3-21 |
| chr14_-_106816253 | 25.13 |
ENST00000390615.2
|
IGHV3-33
|
immunoglobulin heavy variable 3-33 |
| chr17_-_62009621 | 25.09 |
ENST00000349817.2
ENST00000392795.3 |
CD79B
|
CD79b molecule, immunoglobulin-associated beta |
| chr12_-_91573132 | 25.02 |
ENST00000550563.1
ENST00000546370.1 |
DCN
|
decorin |
| chr19_+_35820064 | 24.95 |
ENST00000341773.6
ENST00000600131.1 ENST00000270311.6 ENST00000595780.1 ENST00000597916.1 ENST00000593867.1 ENST00000600424.1 ENST00000599811.1 ENST00000536635.2 ENST00000085219.5 ENST00000544992.2 ENST00000419549.2 |
CD22
|
CD22 molecule |
| chr14_-_106866934 | 24.87 |
ENST00000390618.2
|
IGHV3-38
|
immunoglobulin heavy variable 3-38 (non-functional) |
| chr22_+_23029188 | 24.80 |
ENST00000390305.2
|
IGLV3-25
|
immunoglobulin lambda variable 3-25 |
| chr17_-_62009702 | 24.77 |
ENST00000006750.3
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta |
| chr15_-_20193370 | 24.52 |
ENST00000558565.2
|
IGHV3OR15-7
|
immunoglobulin heavy variable 3/OR15-7 (pseudogene) |
| chr18_-_53089723 | 24.06 |
ENST00000561992.1
ENST00000562512.2 |
TCF4
|
transcription factor 4 |
| chr14_-_107283278 | 23.89 |
ENST00000390639.2
|
IGHV7-81
|
immunoglobulin heavy variable 7-81 (non-functional) |
| chr22_-_24096562 | 23.66 |
ENST00000398465.3
|
VPREB3
|
pre-B lymphocyte 3 |
| chr14_-_107131560 | 23.30 |
ENST00000390632.2
|
IGHV3-66
|
immunoglobulin heavy variable 3-66 |
| chr3_+_49507674 | 22.71 |
ENST00000431960.1
ENST00000452317.1 ENST00000435508.2 ENST00000452060.1 ENST00000428779.1 ENST00000419218.1 ENST00000430636.1 |
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1) |
| chr19_-_39108568 | 22.18 |
ENST00000586296.1
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
| chr15_-_22448819 | 21.91 |
ENST00000604066.1
|
IGHV1OR15-1
|
immunoglobulin heavy variable 1/OR15-1 (non-functional) |
| chr7_-_130080818 | 20.88 |
ENST00000343969.5
ENST00000541543.1 ENST00000489512.1 |
CEP41
|
centrosomal protein 41kDa |
| chr14_-_107219365 | 20.86 |
ENST00000424969.2
|
IGHV3-74
|
immunoglobulin heavy variable 3-74 |
| chr10_-_105452917 | 20.82 |
ENST00000427662.2
|
SH3PXD2A
|
SH3 and PX domains 2A |
| chr1_-_153029980 | 20.26 |
ENST00000392653.2
|
SPRR2A
|
small proline-rich protein 2A |
| chr18_-_53255766 | 20.24 |
ENST00000566286.1
ENST00000564999.1 ENST00000566279.1 ENST00000354452.3 ENST00000356073.4 |
TCF4
|
transcription factor 4 |
| chr8_-_134115118 | 20.16 |
ENST00000395352.3
ENST00000338087.5 |
SLA
|
Src-like-adaptor |
| chr7_-_37024665 | 20.03 |
ENST00000396040.2
|
ELMO1
|
engulfment and cell motility 1 |
| chr17_-_47841485 | 19.90 |
ENST00000506156.1
ENST00000240364.2 |
FAM117A
|
family with sequence similarity 117, member A |
| chr18_-_53257027 | 19.74 |
ENST00000568740.1
ENST00000564403.2 ENST00000537578.1 |
TCF4
|
transcription factor 4 |
| chr9_-_35618364 | 19.33 |
ENST00000378431.1
ENST00000378430.3 ENST00000259633.4 |
CD72
|
CD72 molecule |
| chr19_-_39108552 | 19.27 |
ENST00000591517.1
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
| chr1_-_31230650 | 19.20 |
ENST00000294507.3
|
LAPTM5
|
lysosomal protein transmembrane 5 |
| chr16_+_33629600 | 18.82 |
ENST00000562905.2
|
IGHV3OR16-13
|
immunoglobulin heavy variable 3/OR16-13 (non-functional) |
| chr8_+_56792355 | 18.81 |
ENST00000519728.1
|
LYN
|
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
| chr1_-_153013588 | 18.63 |
ENST00000360379.3
|
SPRR2D
|
small proline-rich protein 2D |
| chr22_-_24096630 | 18.59 |
ENST00000248948.3
|
VPREB3
|
pre-B lymphocyte 3 |
| chr16_+_90089008 | 18.37 |
ENST00000268699.4
|
GAS8
|
growth arrest-specific 8 |
| chr6_+_37137939 | 18.19 |
ENST00000373509.5
|
PIM1
|
pim-1 oncogene |
| chr1_-_153044083 | 18.04 |
ENST00000341611.2
|
SPRR2B
|
small proline-rich protein 2B |
| chr12_-_91576561 | 17.99 |
ENST00000547568.2
ENST00000552962.1 |
DCN
|
decorin |
| chr19_+_19144384 | 17.71 |
ENST00000392335.2
ENST00000535612.1 ENST00000537263.1 ENST00000540707.1 ENST00000541725.1 ENST00000269932.6 ENST00000546344.1 ENST00000540792.1 ENST00000536098.1 ENST00000541898.1 ENST00000543877.1 |
ARMC6
|
armadillo repeat containing 6 |
| chr12_-_91576429 | 17.49 |
ENST00000552145.1
ENST00000546745.1 |
DCN
|
decorin |
| chr8_+_56792377 | 17.44 |
ENST00000520220.2
|
LYN
|
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
| chr15_-_20170354 | 17.22 |
ENST00000338912.5
|
IGHV1OR15-9
|
immunoglobulin heavy variable 1/OR15-9 (non-functional) |
| chr12_-_123201337 | 17.12 |
ENST00000528880.2
|
HCAR3
|
hydroxycarboxylic acid receptor 3 |
| chr14_-_106453155 | 17.00 |
ENST00000390594.2
|
IGHV1-2
|
immunoglobulin heavy variable 1-2 |
| chr1_+_156119798 | 16.75 |
ENST00000355014.2
|
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
| chr4_-_134070250 | 16.52 |
ENST00000505289.1
ENST00000509715.1 |
RP11-9G1.3
|
RP11-9G1.3 |
| chr19_+_13858593 | 16.30 |
ENST00000221554.8
|
CCDC130
|
coiled-coil domain containing 130 |
| chr9_-_127533582 | 16.24 |
ENST00000416460.2
|
NR6A1
|
nuclear receptor subfamily 6, group A, member 1 |
| chr22_+_22936998 | 16.08 |
ENST00000390303.2
|
IGLV3-32
|
immunoglobulin lambda variable 3-32 (non-functional) |
| chr6_-_159421198 | 16.04 |
ENST00000252655.1
ENST00000297262.3 ENST00000367069.2 |
RSPH3
|
radial spoke 3 homolog (Chlamydomonas) |
| chr12_-_7245125 | 16.04 |
ENST00000542285.1
ENST00000540610.1 |
C1R
|
complement component 1, r subcomponent |
| chr14_-_106805716 | 16.00 |
ENST00000438142.2
|
IGHV4-31
|
immunoglobulin heavy variable 4-31 |
| chr7_+_100183927 | 15.83 |
ENST00000241071.6
ENST00000360609.2 |
FBXO24
|
F-box protein 24 |
| chr12_+_25205568 | 15.61 |
ENST00000548766.1
ENST00000556887.1 |
LRMP
|
lymphoid-restricted membrane protein |
| chr9_+_136325089 | 15.61 |
ENST00000291722.7
ENST00000316948.4 ENST00000540581.1 |
CACFD1
|
calcium channel flower domain containing 1 |
| chr12_+_25205666 | 15.42 |
ENST00000547044.1
|
LRMP
|
lymphoid-restricted membrane protein |
| chr19_-_4723761 | 15.26 |
ENST00000597849.1
ENST00000598800.1 ENST00000602161.1 ENST00000597726.1 ENST00000601130.1 ENST00000262960.9 |
DPP9
|
dipeptidyl-peptidase 9 |
| chr12_+_25205446 | 15.15 |
ENST00000557489.1
ENST00000354454.3 ENST00000536173.1 |
LRMP
|
lymphoid-restricted membrane protein |
| chr12_-_16761007 | 15.07 |
ENST00000354662.1
ENST00000441439.2 |
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
| chr12_-_6772303 | 14.65 |
ENST00000396807.4
ENST00000446105.2 ENST00000341550.4 |
ING4
|
inhibitor of growth family, member 4 |
| chr19_-_39108643 | 14.60 |
ENST00000396857.2
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
| chr14_-_106586656 | 14.60 |
ENST00000390602.2
|
IGHV3-13
|
immunoglobulin heavy variable 3-13 |
| chr13_-_99959641 | 14.33 |
ENST00000376414.4
|
GPR183
|
G protein-coupled receptor 183 |
| chr18_+_74240610 | 14.32 |
ENST00000578092.1
ENST00000578613.1 ENST00000583578.1 |
LINC00908
|
long intergenic non-protein coding RNA 908 |
| chr7_-_37488834 | 14.20 |
ENST00000310758.4
|
ELMO1
|
engulfment and cell motility 1 |
| chr22_+_42229100 | 14.18 |
ENST00000361204.4
|
SREBF2
|
sterol regulatory element binding transcription factor 2 |
| chr12_-_91576750 | 14.16 |
ENST00000228329.5
ENST00000303320.3 ENST00000052754.5 |
DCN
|
decorin |
| chr22_+_22550113 | 14.16 |
ENST00000390285.3
|
IGLV6-57
|
immunoglobulin lambda variable 6-57 |
| chrX_-_48776292 | 14.14 |
ENST00000376509.4
|
PIM2
|
pim-2 oncogene |
| chr18_+_42260861 | 14.07 |
ENST00000282030.5
|
SETBP1
|
SET binding protein 1 |
| chr5_+_49961727 | 13.91 |
ENST00000505697.2
ENST00000503750.2 ENST00000514342.2 |
PARP8
|
poly (ADP-ribose) polymerase family, member 8 |
| chr12_+_124997766 | 13.83 |
ENST00000543970.1
|
RP11-83B20.1
|
RP11-83B20.1 |
| chr14_-_106622419 | 13.78 |
ENST00000390604.2
|
IGHV3-16
|
immunoglobulin heavy variable 3-16 (non-functional) |
| chr14_-_106518922 | 13.38 |
ENST00000390598.2
|
IGHV3-7
|
immunoglobulin heavy variable 3-7 |
| chr6_-_24877490 | 13.05 |
ENST00000540914.1
ENST00000378023.4 |
FAM65B
|
family with sequence similarity 65, member B |
| chr5_-_175964366 | 13.03 |
ENST00000274811.4
|
RNF44
|
ring finger protein 44 |
| chr1_+_152975488 | 13.00 |
ENST00000542696.1
|
SPRR3
|
small proline-rich protein 3 |
| chr14_-_106725723 | 12.96 |
ENST00000390609.2
|
IGHV3-23
|
immunoglobulin heavy variable 3-23 |
| chr17_+_14204389 | 12.90 |
ENST00000360954.2
|
HS3ST3B1
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1 |
| chr2_-_99224915 | 12.77 |
ENST00000328709.3
ENST00000409997.1 |
COA5
|
cytochrome c oxidase assembly factor 5 |
| chr1_+_104198377 | 12.75 |
ENST00000370083.4
|
AMY1A
|
amylase, alpha 1A (salivary) |
| chr4_-_46911223 | 12.74 |
ENST00000396533.1
|
COX7B2
|
cytochrome c oxidase subunit VIIb2 |
| chr19_-_19144243 | 12.65 |
ENST00000594445.1
ENST00000452918.2 ENST00000600377.1 ENST00000337018.6 |
SUGP2
|
SURP and G patch domain containing 2 |
| chr9_-_34691201 | 12.59 |
ENST00000378800.3
ENST00000311925.2 |
CCL19
|
chemokine (C-C motif) ligand 19 |
| chr1_+_192778161 | 12.56 |
ENST00000235382.5
|
RGS2
|
regulator of G-protein signaling 2, 24kDa |
| chr4_-_46911248 | 12.50 |
ENST00000355591.3
ENST00000505102.1 |
COX7B2
|
cytochrome c oxidase subunit VIIb2 |
| chr16_-_79634595 | 12.46 |
ENST00000326043.4
ENST00000393350.1 |
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog |
| chr13_-_99910673 | 12.46 |
ENST00000397473.2
ENST00000397470.2 |
GPR18
|
G protein-coupled receptor 18 |
| chr17_-_41465674 | 12.44 |
ENST00000592135.1
ENST00000587874.1 ENST00000588654.1 ENST00000592094.1 |
LINC00910
|
long intergenic non-protein coding RNA 910 |
| chr11_-_64511575 | 12.41 |
ENST00000431822.1
ENST00000377486.3 ENST00000394432.3 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
| chr14_-_106967788 | 12.30 |
ENST00000390622.2
|
IGHV1-46
|
immunoglobulin heavy variable 1-46 |
| chr6_-_52628271 | 12.16 |
ENST00000493422.1
|
GSTA2
|
glutathione S-transferase alpha 2 |
| chr2_+_90259593 | 12.10 |
ENST00000471857.1
|
IGKV1D-8
|
immunoglobulin kappa variable 1D-8 |
| chr19_-_12267524 | 12.08 |
ENST00000455799.1
ENST00000355738.1 ENST00000439556.2 ENST00000542938.1 |
ZNF625
|
zinc finger protein 625 |
| chr12_-_11422630 | 12.08 |
ENST00000381842.3
ENST00000538488.1 |
PRB3
|
proline-rich protein BstNI subfamily 3 |
| chr11_-_62369291 | 11.99 |
ENST00000278823.2
|
MTA2
|
metastasis associated 1 family, member 2 |
| chr1_+_32666188 | 11.88 |
ENST00000421922.2
|
CCDC28B
|
coiled-coil domain containing 28B |
| chr5_+_66254698 | 11.86 |
ENST00000405643.1
ENST00000407621.1 ENST00000432426.1 |
MAST4
|
microtubule associated serine/threonine kinase family member 4 |
| chr22_-_43010928 | 11.83 |
ENST00000348657.2
ENST00000252115.5 |
POLDIP3
|
polymerase (DNA-directed), delta interacting protein 3 |
| chr11_-_2906979 | 11.80 |
ENST00000380725.1
ENST00000313407.6 ENST00000430149.2 ENST00000440480.2 ENST00000414822.3 |
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
| chr2_+_68592305 | 11.76 |
ENST00000234313.7
|
PLEK
|
pleckstrin |
Network of associatons between targets according to the STRING database.
First level regulatory network of POU5F1_POU2F3
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 23.7 | 71.2 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 17.9 | 2692.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 12.1 | 60.6 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
| 12.1 | 36.3 | GO:0070668 | positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
| 10.4 | 124.6 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 9.3 | 27.8 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 7.0 | 21.1 | GO:0019056 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 6.5 | 1120.7 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 5.2 | 20.8 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 4.8 | 14.3 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 4.8 | 23.9 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 4.2 | 12.6 | GO:2000547 | dendritic cell dendrite assembly(GO:0097026) regulation of dendritic cell dendrite assembly(GO:2000547) |
| 4.0 | 8.0 | GO:0002436 | immune complex clearance(GO:0002434) immune complex clearance by monocytes and macrophages(GO:0002436) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) |
| 4.0 | 11.9 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
| 3.9 | 31.4 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 3.8 | 15.4 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 3.7 | 14.6 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 3.6 | 14.3 | GO:0036269 | swimming behavior(GO:0036269) |
| 3.6 | 7.1 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
| 3.6 | 17.8 | GO:2000639 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
| 3.5 | 14.2 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 3.5 | 20.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 3.5 | 17.3 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 3.4 | 13.6 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 3.3 | 16.6 | GO:1900920 | regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
| 3.3 | 13.1 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
| 3.3 | 9.8 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 3.2 | 42.2 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 3.2 | 6.4 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 3.1 | 6.1 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 3.1 | 9.2 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
| 2.7 | 8.2 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 2.7 | 18.9 | GO:0033029 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
| 2.7 | 5.4 | GO:0010958 | regulation of amino acid import(GO:0010958) |
| 2.7 | 8.1 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 2.6 | 18.4 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
| 2.5 | 15.1 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 2.4 | 39.0 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 2.4 | 9.7 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 2.4 | 9.6 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 2.4 | 4.8 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 2.4 | 9.6 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 2.3 | 9.3 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 2.3 | 6.9 | GO:0045666 | positive regulation of neuron differentiation(GO:0045666) |
| 2.3 | 6.9 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
| 2.3 | 6.9 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 2.1 | 12.6 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
| 2.1 | 12.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 2.0 | 12.3 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
| 2.0 | 8.2 | GO:0010165 | response to X-ray(GO:0010165) |
| 2.0 | 28.5 | GO:0002544 | chronic inflammatory response(GO:0002544) |
| 2.0 | 16.3 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 2.0 | 4.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
| 2.0 | 46.0 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
| 2.0 | 16.0 | GO:0009615 | response to virus(GO:0009615) |
| 2.0 | 5.9 | GO:0021571 | rhombomere 3 development(GO:0021569) rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 2.0 | 11.8 | GO:0033625 | positive regulation of integrin activation(GO:0033625) protein secretion by platelet(GO:0070560) |
| 1.9 | 13.6 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
| 1.9 | 7.7 | GO:0030807 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 1.9 | 5.8 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
| 1.9 | 7.7 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
| 1.8 | 12.9 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 1.8 | 9.2 | GO:0030070 | insulin processing(GO:0030070) |
| 1.8 | 5.5 | GO:0071934 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
| 1.8 | 1.8 | GO:0060067 | cervix development(GO:0060067) |
| 1.8 | 33.6 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 1.7 | 18.2 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
| 1.6 | 13.0 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
| 1.6 | 4.9 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 1.6 | 6.4 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 1.6 | 4.8 | GO:0097254 | renal tubular secretion(GO:0097254) |
| 1.6 | 7.9 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 1.6 | 3.2 | GO:0008050 | female courtship behavior(GO:0008050) |
| 1.6 | 9.3 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
| 1.5 | 7.7 | GO:0070842 | aggresome assembly(GO:0070842) |
| 1.5 | 56.3 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 1.5 | 10.6 | GO:0032596 | protein transport within lipid bilayer(GO:0032594) protein transport into membrane raft(GO:0032596) |
| 1.5 | 1.5 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
| 1.5 | 13.3 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 1.5 | 10.3 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 1.5 | 8.8 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 1.4 | 5.8 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) |
| 1.4 | 4.3 | GO:0048852 | hypophysis morphogenesis(GO:0048850) diencephalon morphogenesis(GO:0048852) |
| 1.4 | 5.7 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 1.4 | 5.5 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
| 1.3 | 2.7 | GO:2000366 | regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
| 1.3 | 6.6 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 1.3 | 15.8 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 1.3 | 6.6 | GO:1903960 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) |
| 1.3 | 10.4 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
| 1.3 | 64.9 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 1.3 | 3.8 | GO:0060595 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
| 1.3 | 5.1 | GO:0046671 | negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
| 1.3 | 3.8 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 1.2 | 8.6 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 1.2 | 11.9 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 1.2 | 3.5 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 1.2 | 20.8 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 1.1 | 3.4 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 1.1 | 13.1 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 1.1 | 8.6 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 1.1 | 6.4 | GO:0035799 | ureter maturation(GO:0035799) |
| 1.1 | 5.3 | GO:0016045 | detection of bacterium(GO:0016045) |
| 1.0 | 4.1 | GO:0036343 | psychomotor behavior(GO:0036343) |
| 1.0 | 7.2 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 1.0 | 9.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 1.0 | 3.0 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 1.0 | 4.9 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 1.0 | 5.9 | GO:2000332 | blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
| 1.0 | 3.9 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 1.0 | 2.9 | GO:0061386 | closure of optic fissure(GO:0061386) |
| 1.0 | 3.8 | GO:0030223 | neutrophil differentiation(GO:0030223) |
| 0.9 | 2.8 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.9 | 6.6 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
| 0.9 | 3.7 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.9 | 2.8 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.9 | 10.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.9 | 54.6 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
| 0.9 | 5.3 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 0.9 | 5.3 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.9 | 7.0 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.9 | 5.2 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.9 | 8.6 | GO:0001865 | NK T cell differentiation(GO:0001865) |
| 0.9 | 8.6 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
| 0.9 | 3.4 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.9 | 10.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.9 | 5.1 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.8 | 0.8 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
| 0.8 | 6.6 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.8 | 6.5 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
| 0.8 | 34.2 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.8 | 2.4 | GO:0009447 | putrescine catabolic process(GO:0009447) |
| 0.8 | 3.8 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.8 | 4.5 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) positive regulation of autophagosome maturation(GO:1901098) |
| 0.7 | 11.5 | GO:0031033 | myosin filament organization(GO:0031033) |
| 0.7 | 6.5 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.7 | 7.8 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
| 0.7 | 8.5 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.7 | 7.5 | GO:0006554 | lysine catabolic process(GO:0006554) |
| 0.7 | 3.4 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.7 | 9.9 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.7 | 5.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.6 | 2.6 | GO:0000023 | maltose metabolic process(GO:0000023) |
| 0.6 | 3.2 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.6 | 4.4 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.6 | 2.5 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.6 | 1.9 | GO:0015871 | choline transport(GO:0015871) |
| 0.6 | 1.9 | GO:1903027 | regulation of opsonization(GO:1903027) |
| 0.6 | 11.8 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.6 | 6.8 | GO:0048263 | determination of dorsal identity(GO:0048263) |
| 0.6 | 9.8 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 0.6 | 6.7 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.6 | 4.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.6 | 57.6 | GO:0030183 | B cell differentiation(GO:0030183) |
| 0.6 | 4.7 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
| 0.6 | 5.8 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
| 0.6 | 2.9 | GO:0021759 | globus pallidus development(GO:0021759) |
| 0.6 | 2.9 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.6 | 4.6 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.6 | 6.8 | GO:0044146 | negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.6 | 4.5 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.6 | 7.2 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.6 | 3.3 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.6 | 5.0 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 0.5 | 2.7 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
| 0.5 | 2.2 | GO:1900827 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.5 | 12.9 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
| 0.5 | 2.1 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.5 | 1.6 | GO:0060168 | regulation of adenosine receptor signaling pathway(GO:0060167) positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.5 | 3.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.5 | 5.6 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
| 0.5 | 4.1 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.5 | 9.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.5 | 2.0 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.5 | 16.9 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
| 0.5 | 11.8 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.5 | 9.8 | GO:0036035 | osteoclast development(GO:0036035) |
| 0.5 | 8.7 | GO:0051607 | defense response to virus(GO:0051607) |
| 0.5 | 3.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.5 | 1.4 | GO:2000870 | positive regulation of female gonad development(GO:2000196) regulation of progesterone secretion(GO:2000870) |
| 0.5 | 2.8 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.5 | 2.3 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
| 0.5 | 1.9 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.5 | 1.4 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.5 | 4.6 | GO:0046834 | lipid phosphorylation(GO:0046834) |
| 0.5 | 5.5 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.5 | 1.8 | GO:0015942 | folic acid-containing compound catabolic process(GO:0009397) formate metabolic process(GO:0015942) pteridine-containing compound catabolic process(GO:0042560) |
| 0.4 | 2.2 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.4 | 8.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
| 0.4 | 1.3 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
| 0.4 | 1.7 | GO:0097368 | histone H4-K20 trimethylation(GO:0034773) establishment of Sertoli cell barrier(GO:0097368) |
| 0.4 | 3.0 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
| 0.4 | 9.6 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
| 0.4 | 6.7 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.4 | 8.3 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
| 0.4 | 4.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.4 | 11.2 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.4 | 1.6 | GO:0042220 | response to cocaine(GO:0042220) |
| 0.4 | 8.7 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
| 0.4 | 3.9 | GO:0072672 | neutrophil extravasation(GO:0072672) |
| 0.4 | 27.8 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.4 | 1.2 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.4 | 1.2 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
| 0.4 | 11.7 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
| 0.4 | 1.1 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.4 | 4.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.4 | 15.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.4 | 6.9 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.4 | 2.5 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.4 | 3.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.4 | 6.4 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
| 0.4 | 2.1 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.3 | 1.4 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.3 | 4.8 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
| 0.3 | 2.4 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.3 | 1.7 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.3 | 2.9 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
| 0.3 | 8.4 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.3 | 1.0 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.3 | 4.4 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.3 | 2.2 | GO:0034765 | regulation of ion transmembrane transport(GO:0034765) |
| 0.3 | 2.2 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.3 | 12.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.3 | 3.7 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.3 | 4.0 | GO:0098751 | bone cell development(GO:0098751) |
| 0.3 | 9.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.3 | 10.9 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
| 0.3 | 2.0 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.3 | 74.4 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.3 | 15.4 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
| 0.3 | 3.6 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 0.3 | 2.2 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.3 | 16.3 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.3 | 3.5 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 0.3 | 10.8 | GO:0033344 | cholesterol efflux(GO:0033344) |
| 0.3 | 4.9 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
| 0.3 | 2.7 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.3 | 1.9 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 0.3 | 3.5 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.3 | 5.5 | GO:0030225 | macrophage differentiation(GO:0030225) |
| 0.3 | 8.4 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.3 | 1.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.3 | 3.6 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
| 0.3 | 1.8 | GO:0015870 | acetylcholine transport(GO:0015870) |
| 0.3 | 3.3 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.3 | 5.1 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
| 0.3 | 2.3 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.3 | 5.8 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.3 | 1.3 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
| 0.2 | 1.2 | GO:0032364 | oxygen homeostasis(GO:0032364) |
| 0.2 | 1.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
| 0.2 | 5.0 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.2 | 8.6 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.2 | 1.6 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.2 | 1.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.2 | 8.2 | GO:0019228 | neuronal action potential(GO:0019228) |
| 0.2 | 2.0 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.2 | 0.7 | GO:0006114 | glycerol biosynthetic process(GO:0006114) response to methionine(GO:1904640) |
| 0.2 | 1.5 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 0.2 | 2.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.2 | 4.2 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 0.2 | 4.2 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.2 | 30.8 | GO:0006906 | vesicle fusion(GO:0006906) |
| 0.2 | 1.6 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.2 | 4.6 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
| 0.2 | 14.0 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 0.2 | 2.5 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.2 | 3.0 | GO:0001709 | cell fate determination(GO:0001709) |
| 0.2 | 3.2 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.2 | 35.5 | GO:0002250 | adaptive immune response(GO:0002250) |
| 0.2 | 0.6 | GO:2000342 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.2 | 6.3 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.2 | 2.0 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.2 | 8.1 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.2 | 2.2 | GO:0042306 | regulation of protein import into nucleus(GO:0042306) regulation of protein import(GO:1904589) |
| 0.2 | 7.7 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.2 | 3.9 | GO:0045576 | mast cell activation(GO:0045576) |
| 0.2 | 6.8 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.2 | 1.5 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
| 0.2 | 3.2 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.2 | 1.9 | GO:0060037 | pharyngeal system development(GO:0060037) |
| 0.2 | 0.3 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.1 | 4.5 | GO:0042417 | dopamine metabolic process(GO:0042417) |
| 0.1 | 0.6 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.1 | 2.3 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
| 0.1 | 3.4 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.1 | 1.0 | GO:1903169 | regulation of calcium ion transmembrane transport(GO:1903169) |
| 0.1 | 1.7 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
| 0.1 | 0.7 | GO:0048665 | neuron fate specification(GO:0048665) |
| 0.1 | 5.1 | GO:1903845 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
| 0.1 | 0.4 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.1 | 1.2 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.1 | 3.6 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.1 | 3.4 | GO:0007409 | axonogenesis(GO:0007409) |
| 0.1 | 6.0 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.1 | 3.1 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.1 | 8.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.1 | 1.2 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.1 | 4.5 | GO:0060976 | coronary vasculature development(GO:0060976) |
| 0.1 | 0.7 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.1 | 8.7 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.1 | 1.2 | GO:0001756 | somitogenesis(GO:0001756) |
| 0.1 | 2.1 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 | 2.5 | GO:0033198 | response to ATP(GO:0033198) |
| 0.1 | 1.6 | GO:0050860 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 | 2.7 | GO:0014047 | glutamate secretion(GO:0014047) |
| 0.1 | 0.4 | GO:0009629 | response to gravity(GO:0009629) |
| 0.1 | 0.5 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.1 | 3.2 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.1 | 0.9 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
| 0.1 | 3.1 | GO:0060711 | labyrinthine layer development(GO:0060711) |
| 0.1 | 1.0 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.1 | 6.7 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.1 | 2.5 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 | 6.3 | GO:0007631 | feeding behavior(GO:0007631) |
| 0.1 | 1.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 | 10.7 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
| 0.1 | 7.8 | GO:0034332 | adherens junction organization(GO:0034332) |
| 0.1 | 0.5 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.1 | 1.8 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 0.1 | 1.0 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.1 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 | 4.0 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.1 | 0.9 | GO:0021549 | cerebellum development(GO:0021549) metencephalon development(GO:0022037) |
| 0.1 | 2.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 | 2.0 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.1 | 0.5 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.1 | 1.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 | 1.0 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.1 | 1.9 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 0.0 | 1.4 | GO:0003407 | neural retina development(GO:0003407) |
| 0.0 | 0.4 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
| 0.0 | 1.4 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
| 0.0 | 5.2 | GO:0043406 | positive regulation of MAP kinase activity(GO:0043406) |
| 0.0 | 1.2 | GO:0003091 | renal water homeostasis(GO:0003091) |
| 0.0 | 0.4 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
| 0.0 | 0.5 | GO:0021591 | ventricular system development(GO:0021591) |
| 0.0 | 0.1 | GO:0086097 | renin-angiotensin regulation of aldosterone production(GO:0002018) regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) regulation of cholesterol esterification(GO:0010872) positive regulation of cholesterol esterification(GO:0010873) phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.0 | 0.5 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
| 0.0 | 1.2 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
| 0.0 | 1.1 | GO:0017156 | calcium ion regulated exocytosis(GO:0017156) |
| 0.0 | 1.0 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
| 0.0 | 0.1 | GO:0014874 | response to muscle inactivity(GO:0014870) response to stimulus involved in regulation of muscle adaptation(GO:0014874) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.0 | 1.8 | GO:0070268 | cornification(GO:0070268) |
| 0.0 | 0.2 | GO:0002507 | tolerance induction(GO:0002507) |
| 0.0 | 0.8 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.0 | 0.2 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.0 | 0.0 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.0 | 0.6 | GO:0038034 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
| 0.0 | 0.0 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.0 | 0.7 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 | 0.1 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 19.8 | 59.4 | GO:0071745 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
| 16.8 | 790.4 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 8.9 | 124.6 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 7.3 | 36.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 7.1 | 49.9 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 4.2 | 88.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 3.5 | 14.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 3.4 | 13.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 3.2 | 16.1 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 2.9 | 529.1 | GO:0072562 | blood microparticle(GO:0072562) |
| 2.9 | 34.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 2.5 | 17.8 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 2.3 | 9.3 | GO:0043293 | apoptosome(GO:0043293) |
| 2.3 | 11.6 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 2.3 | 6.9 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
| 2.2 | 11.1 | GO:0005579 | membrane attack complex(GO:0005579) |
| 2.2 | 8.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 2.1 | 8.6 | GO:1990031 | pinceau fiber(GO:1990031) |
| 1.8 | 9.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 1.8 | 15.8 | GO:0071953 | elastic fiber(GO:0071953) |
| 1.7 | 17.3 | GO:0070938 | contractile ring(GO:0070938) |
| 1.6 | 9.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 1.6 | 27.2 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
| 1.4 | 7.0 | GO:0044308 | axonal spine(GO:0044308) |
| 1.4 | 9.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
| 1.3 | 8.1 | GO:0032009 | early phagosome(GO:0032009) |
| 1.3 | 4.0 | GO:0036398 | TCR signalosome(GO:0036398) |
| 1.2 | 6.2 | GO:0045298 | tubulin complex(GO:0045298) |
| 1.2 | 65.0 | GO:0001533 | cornified envelope(GO:0001533) |
| 1.2 | 7.3 | GO:0000322 | storage vacuole(GO:0000322) |
| 1.2 | 3.6 | GO:0032437 | cuticular plate(GO:0032437) |
| 1.1 | 8.5 | GO:0036157 | outer dynein arm(GO:0036157) |
| 1.0 | 5.2 | GO:0071546 | pi-body(GO:0071546) |
| 0.9 | 1451.5 | GO:0005615 | extracellular space(GO:0005615) |
| 0.8 | 77.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.8 | 5.0 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
| 0.8 | 9.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.8 | 11.8 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.8 | 2.3 | GO:0097447 | dendritic tree(GO:0097447) |
| 0.8 | 10.8 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.7 | 2.1 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.7 | 5.5 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.7 | 2.6 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.7 | 39.0 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.6 | 22.9 | GO:0016592 | mediator complex(GO:0016592) |
| 0.6 | 3.0 | GO:0089701 | U2AF(GO:0089701) |
| 0.6 | 3.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.6 | 8.0 | GO:0005687 | U4 snRNP(GO:0005687) |
| 0.6 | 9.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.6 | 3.4 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.6 | 7.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.5 | 15.6 | GO:0001726 | ruffle(GO:0001726) |
| 0.5 | 2.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.5 | 30.5 | GO:0030427 | site of polarized growth(GO:0030427) |
| 0.5 | 8.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.5 | 9.1 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.5 | 23.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.5 | 5.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.4 | 35.1 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.4 | 23.4 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.4 | 6.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.4 | 11.1 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.4 | 11.2 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.4 | 13.0 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 0.3 | 5.1 | GO:0046930 | pore complex(GO:0046930) |
| 0.3 | 1.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.3 | 11.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.3 | 38.7 | GO:0016605 | PML body(GO:0016605) |
| 0.3 | 22.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.3 | 6.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.3 | 4.5 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 0.3 | 11.6 | GO:0008305 | integrin complex(GO:0008305) |
| 0.3 | 2.4 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.3 | 14.2 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.3 | 3.3 | GO:0030673 | axolemma(GO:0030673) |
| 0.3 | 6.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 0.3 | 14.2 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.3 | 6.5 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.3 | 3.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.3 | 2.3 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
| 0.3 | 16.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.2 | 2.7 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.2 | 48.1 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.2 | 0.5 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.2 | 9.4 | GO:0016235 | aggresome(GO:0016235) |
| 0.2 | 6.4 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.2 | 3.6 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.2 | 1.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.2 | 6.1 | GO:0044309 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
| 0.2 | 5.4 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.2 | 2.2 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.2 | 1.4 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.2 | 4.6 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.2 | 1.2 | GO:0097361 | CIA complex(GO:0097361) |
| 0.2 | 1.6 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.2 | 17.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.2 | 4.5 | GO:0043204 | perikaryon(GO:0043204) |
| 0.2 | 7.7 | GO:0005902 | microvillus(GO:0005902) |
| 0.1 | 4.3 | GO:0000791 | euchromatin(GO:0000791) |
| 0.1 | 1.0 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.1 | 614.5 | GO:0005886 | plasma membrane(GO:0005886) |
| 0.1 | 14.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.1 | 2.9 | GO:0031093 |